Terms: = Lymphoma AND RUNX1T1, ENSG00000079102, 862 AND Prognosis
17 results:
1. Clinicopathologic Characteristics Associated with prognosis in Ocular Extranodal Marginal Zone B Cell lymphoma.
Choi S; Seo M; Park SH; Jo JC; Chae SW; Lee JH; Cha HJ
Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744081
[No Abstract] [Full Text] [Related]
2. Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial.
Camus V; Belot A; Oberic L; Sibon D; Ghesquières H; Thieblemont C; Fruchart C; Casasnovas O; Michot JM; Molina TJ; Bosly A; Joubert C; Haioun C; Nicolas-Virelizier E; Feugier P; Fitoussi O; Delarue R; Tilly H
Blood Adv; 2022 Dec; 6(24):6169-6179. PubMed ID: 35737565
[TBL] [Abstract] [Full Text] [Related]
3. Utility of Epstein-Barr Viral Load in Blood for Diagnosing and Predicting prognosis of lymphoma: A Comparison with Epstein-Barr Virus-Encoded RNA in Situ Hybridization.
Song J; Kim JY; Kim S; Park Y
J Mol Diagn; 2022 Sep; 24(9):977-991. PubMed ID: 35718093
[TBL] [Abstract] [Full Text] [Related]
4. [Development of acute kidney injury prognostic model for critically ill patients based on MIMIC-III database].
Li M; Yang H; Yang W; Wei B; Zhang Y; Xie R; Chu P
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Aug; 33(8):949-954. PubMed ID: 34590562
[TBL] [Abstract] [Full Text] [Related]
5. Association of minimal residual disease with clinical outcomes in Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A systemic literature review and meta-analysis.
Zhang W; Jang E
PLoS One; 2021; 16(8):e0256801. PubMed ID: 34437635
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological Evaluation of Acute Leukemias in a Tertiary Care Hospital: A Cross-Sectional Study.
Patel GN; Gudur R; Gudur A; Oswal RM; Kanethkar S
Turk Patoloji Derg; 2021; 37(2):145-153. PubMed ID: 33973643
[TBL] [Abstract] [Full Text] [Related]
7. The clinical mutatome of core binding factor leukemia.
Opatz S; Bamopoulos SA; Metzeler KH; Herold T; Ksienzyk B; Bräundl K; Tschuri S; Vosberg S; Konstandin NP; Wang C; Hartmann L; Graf A; Krebs S; Blum H; Schneider S; Thiede C; Middeke JM; Stölzel F; Röllig C; Schetelig J; Ehninger G; Krämer A; Braess J; Görlich D; Sauerland MC; Berdel WE; Wörmann BJ; Hiddemann W; Spiekermann K; Bohlander SK; Greif PA
Leukemia; 2020 Jun; 34(6):1553-1562. PubMed ID: 31896782
[TBL] [Abstract] [Full Text] [Related]
8. First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients.
Janikova A; Chloupkova R; Campr V; Klener P; Hamouzova J; Belada D; Prochazka V; Pytlik R; Pirnos J; Duras J; Mocikova H; Bortlicek Z; Kopalova N; Mayer J; Trneny M
Ann Hematol; 2019 Aug; 98(8):1961-1972. PubMed ID: 31065733
[TBL] [Abstract] [Full Text] [Related]
9. The Incidence and Immunophenotypic and Genetic Features of JL1 Expressing Cells and the Therapeutic Potential of an Anti-JL1 Antibody in
Park SH; You E; Park CJ; Jang S; Cho YU; Yoon CH; Koh KN; Im HJ; Seo JJ
Ann Lab Med; 2019 Jul; 39(4):358-366. PubMed ID: 30809981
[TBL] [Abstract] [Full Text] [Related]
10. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
[TBL] [Abstract] [Full Text] [Related]
11. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
[TBL] [Abstract] [Full Text] [Related]
12. ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-runx1t1 and associated with a better prognosis.
Yamato G; Shiba N; Yoshida K; Shiraishi Y; Hara Y; Ohki K; Okubo J; Okuno H; Chiba K; Tanaka H; Kinoshita A; Moritake H; Kiyokawa N; Tomizawa D; Park MJ; Sotomatsu M; Taga T; Adachi S; Tawa A; Horibe K; Arakawa H; Miyano S; Ogawa S; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):382-393. PubMed ID: 28063196
[TBL] [Abstract] [Full Text] [Related]
13. Multiplexed automated digital quantification of fusion transcripts: comparative study with fluorescent in-situ hybridization (FISH) technique in acute leukemia patients.
Akhter A; Mughal MK; Elyamany G; Sinclair G; Azma RZ; Masir N; Shuib S; Rashid-Kolvear F; Shabani-Rad MT; Stewart DA; Mansoor A
Diagn Pathol; 2016 Sep; 11(1):89. PubMed ID: 27632978
[TBL] [Abstract] [Full Text] [Related]
14. MYC protein expression is associated with poor prognosis in diffuse large B cell lymphoma patients treated with RCHOP chemotherapy.
Zhou M; Wang J; Ouyang J; Xu JY; Chen B; Zhang QG; Zhou RF; Yang YG; Shao XY; Xu Y; Chen YM; Fan XS; Wu HY
Tumour Biol; 2014 Jul; 35(7):6757-62. PubMed ID: 24719189
[TBL] [Abstract] [Full Text] [Related]
15. Factors affecting survival in patients aged 60 and over with diffuse large B cell lymphoma failing first-line therapy.
Lowry L; Smith P; Cunningham D; Linch DC
J Geriatr Oncol; 2013 Apr; 4(2):134-40. PubMed ID: 24071538
[TBL] [Abstract] [Full Text] [Related]
16. Genetic changes including gene copy number alterations and their relation to prognosis in childhood acute myeloid leukemia.
Armengol G; Canellas A; Alvarez Y; Bastida P; Toledo JS; Pérez-Iribarne Mdel M; Camós M; Tuset E; Estella J; Coll MD; Caballín MR; Knuutila S
Leuk Lymphoma; 2010 Jan; 51(1):114-24. PubMed ID: 20001230
[TBL] [Abstract] [Full Text] [Related]
17. Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.
Koren G; Ferrazini G; Sulh H; Langevin AM; Kapelushnik J; Klein J; Giesbrecht E; Soldin S; Greenberg M
N Engl J Med; 1990 Jul; 323(1):17-21. PubMed ID: 2355954
[TBL] [Abstract] [Full Text] [Related]
